All men with vasculogenic erectile dysfunction require a cardiovascular workup

Martin Miner, Ajay Nehra, Graham Jackson, Shalender Bhasin, Kevin Billups, Arthur L. Burnett, Jacques Buvat, Culley Carson, Glenn Cunningham, Peter Ganz, Irwin Goldstein, Andre Guay, Geoff Hackett, Robert A. Kloner, John B. Kostis, K. Elizabeth Laflamme, Piero Montorsi, Melinda Ramsey, Raymond Rosen, Richard SadovskyAllen Seftel, Ridwan Shabsigh, Charalambos Vlachopoulos, Frederick Wu

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk. Therefore, assessment and management of erectile dysfunction may help identify and reduce the risk of future cardiovascular events, particularly in younger men. The initial erectile dysfunction evaluation should distinguish between predominantly vasculogenic erectile dysfunction and erectile dysfunction of other etiologies. For men believed to have predominantly vasculogenic erectile dysfunction, we recommend that initial cardiovascular risk stratification be based on the Framingham Risk Score. Management of men with erectile dysfunction who are at low risk for cardiovascular disease should focus on risk-factor control; men at high risk, including those with cardiovascular symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo noninvasive evaluation for subclinical atherosclerosis. A growing body of evidence supports the use of emerging prognostic markers to further understand cardiovascular risk in men with erectile dysfunction, but few markers have been prospectively evaluated in this population. In conclusion, we support cardiovascular risk stratification and risk-factor management in all men with vasculogenic erectile dysfunction.

Original languageEnglish
Pages (from-to)174-182
Number of pages9
JournalAmerican Journal of Medicine
Volume127
Issue number3
DOIs
Publication statusPublished - Mar 2014

Fingerprint

Erectile Dysfunction
Cardiovascular Diseases
Risk Management
Atherosclerosis

Keywords

  • Cardiovascular disease
  • Erectile dysfunction
  • Evaluation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Miner, M., Nehra, A., Jackson, G., Bhasin, S., Billups, K., Burnett, A. L., ... Wu, F. (2014). All men with vasculogenic erectile dysfunction require a cardiovascular workup. American Journal of Medicine, 127(3), 174-182. https://doi.org/10.1016/j.amjmed.2013.10.013

All men with vasculogenic erectile dysfunction require a cardiovascular workup. / Miner, Martin; Nehra, Ajay; Jackson, Graham; Bhasin, Shalender; Billups, Kevin; Burnett, Arthur L.; Buvat, Jacques; Carson, Culley; Cunningham, Glenn; Ganz, Peter; Goldstein, Irwin; Guay, Andre; Hackett, Geoff; Kloner, Robert A.; Kostis, John B.; Laflamme, K. Elizabeth; Montorsi, Piero; Ramsey, Melinda; Rosen, Raymond; Sadovsky, Richard; Seftel, Allen; Shabsigh, Ridwan; Vlachopoulos, Charalambos; Wu, Frederick.

In: American Journal of Medicine, Vol. 127, No. 3, 03.2014, p. 174-182.

Research output: Contribution to journalArticle

Miner, M, Nehra, A, Jackson, G, Bhasin, S, Billups, K, Burnett, AL, Buvat, J, Carson, C, Cunningham, G, Ganz, P, Goldstein, I, Guay, A, Hackett, G, Kloner, RA, Kostis, JB, Laflamme, KE, Montorsi, P, Ramsey, M, Rosen, R, Sadovsky, R, Seftel, A, Shabsigh, R, Vlachopoulos, C & Wu, F 2014, 'All men with vasculogenic erectile dysfunction require a cardiovascular workup', American Journal of Medicine, vol. 127, no. 3, pp. 174-182. https://doi.org/10.1016/j.amjmed.2013.10.013
Miner, Martin ; Nehra, Ajay ; Jackson, Graham ; Bhasin, Shalender ; Billups, Kevin ; Burnett, Arthur L. ; Buvat, Jacques ; Carson, Culley ; Cunningham, Glenn ; Ganz, Peter ; Goldstein, Irwin ; Guay, Andre ; Hackett, Geoff ; Kloner, Robert A. ; Kostis, John B. ; Laflamme, K. Elizabeth ; Montorsi, Piero ; Ramsey, Melinda ; Rosen, Raymond ; Sadovsky, Richard ; Seftel, Allen ; Shabsigh, Ridwan ; Vlachopoulos, Charalambos ; Wu, Frederick. / All men with vasculogenic erectile dysfunction require a cardiovascular workup. In: American Journal of Medicine. 2014 ; Vol. 127, No. 3. pp. 174-182.
@article{b183b8ffdfc640b0a854724d58282d74,
title = "All men with vasculogenic erectile dysfunction require a cardiovascular workup",
abstract = "An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk. Therefore, assessment and management of erectile dysfunction may help identify and reduce the risk of future cardiovascular events, particularly in younger men. The initial erectile dysfunction evaluation should distinguish between predominantly vasculogenic erectile dysfunction and erectile dysfunction of other etiologies. For men believed to have predominantly vasculogenic erectile dysfunction, we recommend that initial cardiovascular risk stratification be based on the Framingham Risk Score. Management of men with erectile dysfunction who are at low risk for cardiovascular disease should focus on risk-factor control; men at high risk, including those with cardiovascular symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo noninvasive evaluation for subclinical atherosclerosis. A growing body of evidence supports the use of emerging prognostic markers to further understand cardiovascular risk in men with erectile dysfunction, but few markers have been prospectively evaluated in this population. In conclusion, we support cardiovascular risk stratification and risk-factor management in all men with vasculogenic erectile dysfunction.",
keywords = "Cardiovascular disease, Erectile dysfunction, Evaluation",
author = "Martin Miner and Ajay Nehra and Graham Jackson and Shalender Bhasin and Kevin Billups and Burnett, {Arthur L.} and Jacques Buvat and Culley Carson and Glenn Cunningham and Peter Ganz and Irwin Goldstein and Andre Guay and Geoff Hackett and Kloner, {Robert A.} and Kostis, {John B.} and Laflamme, {K. Elizabeth} and Piero Montorsi and Melinda Ramsey and Raymond Rosen and Richard Sadovsky and Allen Seftel and Ridwan Shabsigh and Charalambos Vlachopoulos and Frederick Wu",
year = "2014",
month = "3",
doi = "10.1016/j.amjmed.2013.10.013",
language = "English",
volume = "127",
pages = "174--182",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - All men with vasculogenic erectile dysfunction require a cardiovascular workup

AU - Miner, Martin

AU - Nehra, Ajay

AU - Jackson, Graham

AU - Bhasin, Shalender

AU - Billups, Kevin

AU - Burnett, Arthur L.

AU - Buvat, Jacques

AU - Carson, Culley

AU - Cunningham, Glenn

AU - Ganz, Peter

AU - Goldstein, Irwin

AU - Guay, Andre

AU - Hackett, Geoff

AU - Kloner, Robert A.

AU - Kostis, John B.

AU - Laflamme, K. Elizabeth

AU - Montorsi, Piero

AU - Ramsey, Melinda

AU - Rosen, Raymond

AU - Sadovsky, Richard

AU - Seftel, Allen

AU - Shabsigh, Ridwan

AU - Vlachopoulos, Charalambos

AU - Wu, Frederick

PY - 2014/3

Y1 - 2014/3

N2 - An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk. Therefore, assessment and management of erectile dysfunction may help identify and reduce the risk of future cardiovascular events, particularly in younger men. The initial erectile dysfunction evaluation should distinguish between predominantly vasculogenic erectile dysfunction and erectile dysfunction of other etiologies. For men believed to have predominantly vasculogenic erectile dysfunction, we recommend that initial cardiovascular risk stratification be based on the Framingham Risk Score. Management of men with erectile dysfunction who are at low risk for cardiovascular disease should focus on risk-factor control; men at high risk, including those with cardiovascular symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo noninvasive evaluation for subclinical atherosclerosis. A growing body of evidence supports the use of emerging prognostic markers to further understand cardiovascular risk in men with erectile dysfunction, but few markers have been prospectively evaluated in this population. In conclusion, we support cardiovascular risk stratification and risk-factor management in all men with vasculogenic erectile dysfunction.

AB - An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk. Therefore, assessment and management of erectile dysfunction may help identify and reduce the risk of future cardiovascular events, particularly in younger men. The initial erectile dysfunction evaluation should distinguish between predominantly vasculogenic erectile dysfunction and erectile dysfunction of other etiologies. For men believed to have predominantly vasculogenic erectile dysfunction, we recommend that initial cardiovascular risk stratification be based on the Framingham Risk Score. Management of men with erectile dysfunction who are at low risk for cardiovascular disease should focus on risk-factor control; men at high risk, including those with cardiovascular symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo noninvasive evaluation for subclinical atherosclerosis. A growing body of evidence supports the use of emerging prognostic markers to further understand cardiovascular risk in men with erectile dysfunction, but few markers have been prospectively evaluated in this population. In conclusion, we support cardiovascular risk stratification and risk-factor management in all men with vasculogenic erectile dysfunction.

KW - Cardiovascular disease

KW - Erectile dysfunction

KW - Evaluation

UR - http://www.scopus.com/inward/record.url?scp=84894317154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894317154&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2013.10.013

DO - 10.1016/j.amjmed.2013.10.013

M3 - Article

C2 - 24423973

AN - SCOPUS:84894317154

VL - 127

SP - 174

EP - 182

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -